...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Additional Reports Of Exempt Distribution.
Reply New Message
Back To Forum List View

1) Promissory Note: Dated 2024-05-09 for $ 68,460.00

With 85K warrants @ $1.03 expire, 2029-05-09

 

2) Promissory Note: Dated 2024-05-28 for $ 713,398.00

With 700K warrants @ $1.02 expire, 2029-05-28

*Both are out of Alberta. 

 

Koo

1 Recommendations
Re: Additional Reports Of Exempt Distribution.

fuzzyjr
Jun 05, 2024 04:27PM
Re: Additional Reports Of Exempt Distribution.
1
KOO-KOO2
Jun 05, 2024 08:46PM
Re: Additional Reports Of Exempt Distribution.

fuzzyjr
Jun 05, 2024 09:18PM
Re: Additional Reports Of Exempt Distribution.
2
tada
Jun 05, 2024 10:55PM
Re: Additional Reports Of Exempt Distribution.
1
fuzzyjr
Jun 05, 2024 11:17PM
Re: Additional Reports Of Exempt Distribution.

fuzzyjr
Jun 05, 2024 11:28PM
Re: Additional Reports Of Exempt Distribution.

KOO-KOO2
Jun 06, 2024 08:28AM
Icon president Re: Additional Reports Of Exempt Distribution.
3
fouremm
Jun 06, 2024 10:11AM
Re: Additional Reports Of Exempt Distribution.

fuzzyjr
Jun 06, 2024 10:20AM
Re: Additional Reports Of Exempt Distribution.
4
jonzobot
Jun 06, 2024 11:25AM
Icon president Re: Additional Reports Of Exempt Distribution.
6
RVXoldtimer
Jun 06, 2024 01:56PM
Icon president Re: Additional Reports Of Exempt Distribution.
2
fouremm
Jun 07, 2024 11:10AM
Re: Additional Reports Of Exempt Distribution.
2
KOO-KOO2
Jun 20, 2024 12:47PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply